, a respected developer of extended autologous cellular treatments for the treatment of severe cardiovascular illnesses, today announced an interim analysis of all 86 patients signed up for the business’s Phase 2b RESTORE-CLI medical trial shows that the analysis achieved both its major safety endpoint and major efficacy endpoint of period to first occurrence of treatment failing. The findings related to time to initial occurrence of treatment failure had been statistically significant> This interim analysis includes outcomes from all 86 patients who were randomized and signed up for the trial, 72 of whom were qualified to receive treatment and have completed at least six months of follow-up and 62 of whom completed 12 months of follow-up.D., chief of vascular surgery at Dartmouth-Hitchcock INFIRMARY in Lebanon, NH.The Department of Homeland Protection announced that, starting this full week, travelers from Ebola-stricken countries will have to undergo enhanced security screenings. The five airports consist of John F. Kennedy International Airport in NY, Newark in NJ, Washington-Dulles near D.C., Chicago-O’Hare, and Hartsfield-Jackson AIRPORT TERMINAL in Atlanta, Georgia. West African travelers getting into these airports will be subject to no-touch temperature checks to look for fevers, a common indicator of Ebola. We are working carefully with the airlines to implement these restrictions with minimal travel disruption, announced Jeh Johnson, DHS secretary. If not already handled by the airlines, the few impacted travelers should get in touch with the airlines for rebooking, as needed.